Mumbai-based pharmaceutical firm Cipla is ready to launch coronavirus drug Favipiravir for the treatment of COVID-19 patients, according to an official statement released by the Council of Scientific and Industrial Research (CSIR) on Thursday (July 23, 2020).
https://ift.tt/eA8V8J from https://ift.tt/2CHTwTR
ليست هناك تعليقات:
إرسال تعليق